*4.4.3 India*

India is one of the world most populated country with weak health care systems are exposed to resistant pathogens. In comparison to Pakistan, China, and Iran it has a similar prevalence rate of resistance, In India, the prevalence of ESBLs producing *E. coli* has been observed in a range between 45 and 79% [116]. *CTX-M-15* produces *E. coli* colonization was most common especially among children [55%] who were admitted in intensive care unit (ICU) [117]. Another report from South India where *CTX-M* positive cases were reported in more than 60% of *E. coli* isolates [118]. In all reported the most frequent isolated group was *CTX-M-1* group *E. coli*. In India, the frequency of ESBL producing *E. coli* was 23% among UTIs patients, with *CTX-M-15* and ST-131 *E. coli* strain was the highest [119].
